Grape King Bio Ltd (TPE:1707)
Taiwan · Delayed Price · Currency is TWD 89.20
+0.80 (0.90%)
Aug 7, 2026, 1:30 PM CST
Grape King Bio Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,095 | 18,739 | 22,147 | 23,109 | 24,887 | 23,702 | |
Market Cap Growth | -31.47% | -15.38% | -4.17% | -7.14% | 5.00% | -2.02% |
Enterprise Value | 11,041 | 17,195 | 20,448 | 21,143 | 23,112 | 22,611 |
Last Close Price | 88.40 | 119.72 | 134.36 | 134.17 | 138.86 | 126.63 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 11.13 | 15.38 | 15.29 | 15.91 | 17.08 | 18.23 |
Forward PE | - | 13.25 | 13.84 | 14.63 | 16.83 | 16.92 |
PS Ratio | 1.27 | 1.83 | 1.98 | 2.17 | 2.40 | 2.42 |
PB Ratio | 1.11 | 1.55 | 1.88 | 1.99 | 2.23 | 2.27 |
P/TBV Ratio | 1.32 | 1.83 | 2.23 | 2.35 | 2.61 | 2.65 |
P/FCF Ratio | 6.62 | 10.81 | 17.73 | 11.96 | 9.94 | 10.46 |
P/OCF Ratio | 5.14 | 8.60 | 11.81 | 9.17 | 8.32 | 9.32 |
PEG Ratio | - | 1.11 | 1.11 | 1.11 | 1.11 | 1.11 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.07 | 1.68 | 1.83 | 1.99 | 2.22 | 2.31 |
EV/EBITDA Ratio | 4.17 | 6.62 | 6.97 | 7.15 | 7.87 | 8.44 |
EV/EBIT Ratio | 5.21 | 8.03 | 8.18 | 8.47 | 9.06 | 9.78 |
EV/FCF Ratio | 5.58 | 9.91 | 16.37 | 10.94 | 9.23 | 9.97 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.08 | 0.08 | 0.05 | 0.07 | 0.05 | 0.10 |
Debt / FCF Ratio | 0.10 | 0.12 | 0.13 | 0.10 | 0.06 | 0.12 |
Net Debt / Equity Ratio | -0.33 | -0.34 | -0.36 | -0.41 | -0.42 | -0.35 |
Net Debt / EBITDA Ratio | -1.52 | -1.56 | -1.46 | -1.62 | -1.58 | -1.35 |
Net Debt / FCF Ratio | -1.97 | -2.34 | -3.42 | -2.47 | -1.85 | -1.60 |
Asset Turnover | 0.68 | 0.66 | 0.72 | 0.70 | 0.71 | 0.72 |
Inventory Turnover | 3.16 | 2.85 | 3.33 | 3.01 | 2.63 | 2.65 |
Quick Ratio | 1.33 | 1.36 | 1.44 | 1.45 | 1.37 | 1.28 |
Current Ratio | 1.60 | 1.66 | 1.68 | 1.66 | 1.56 | 1.51 |
Return on Equity (ROE) | 15.58% | 15.60% | 18.54% | 18.81% | 20.12% | 21.16% |
Return on Assets (ROA) | 8.64% | 8.62% | 10.13% | 10.21% | 10.96% | 10.64% |
Return on Invested Capital (ROIC) | 21.33% | 22.35% | 28.25% | 30.08% | 30.95% | 26.90% |
Return on Capital Employed (ROCE) | 17.40% | 17.40% | 20.80% | 21.00% | 22.50% | 21.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.05% | 6.50% | 6.54% | 6.29% | 5.85% | 5.49% |
FCF Yield | 15.11% | 9.25% | 5.64% | 8.36% | 10.06% | 9.56% |
Dividend Yield | 6.76% | 5.01% | 5.13% | 5.14% | 4.97% | 4.82% |
Payout Ratio | 79.98% | 83.90% | 70.58% | 70.36% | 62.02% | 72.91% |
Buyback Yield / Dilution | -0.01% | 0.01% | -0.01% | -0.06% | -0.45% | -8.41% |
Total Shareholder Return | 6.76% | 5.02% | 5.13% | 5.08% | 4.52% | -3.59% |